Relaxin Suppresses Atrial Fibrillation In 24 Month Old Rats By Reversing Atrial Fibrosis And Upregulating Sodium Channels

Atrial fibrillation (AF) contributes significantly to morbidity and mortality in elderly patients and AF has been strongly correlated with the development of atrial fibrosis. Therefore, the antifibrotic hormone relaxin (RLX) was studied as a novel therapy for AF and age related fibrosis.24 month